Works matching AU Chien, Rong‐Nan


Results: 117
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Five‐year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment‐naïve patients with chronic hepatitis B‐related compensated cirrhosis in Taiwan.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 11/12, p. 1695, doi. 10.1111/apt.16116
    By:
    • Hu, Tsung‐Hui;
    • Yueh‐Hsia Chiu, Sherry;
    • Tseng, Po‐Lin;
    • Chen, Chien‐Hung;
    • Lu, Sheng‐Nan;
    • Wang, Jing‐Houng;
    • Hung, Chao‐Hung;
    • Kee, Kwong‐Ming;
    • Lin, Ming‐Tsung;
    • Chang, Kuo‐Chin;
    • Lin, Meng‐Chih;
    • Chien, Rong‐Nan
    Publication type:
    Article
    13

    Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosis.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 8, p. 1399, doi. 10.1111/apt.16067
    By:
    • Sonneveld, Milan J.;
    • Brouwer, Willem P.;
    • Hansen, Bettina E.;
    • Chan, Henry L.‐Y.;
    • Piratvisuth, Teerha;
    • Jia, Ji‐Dong;
    • Zeuzem, Stefan;
    • Chien, Rong‐Nan;
    • Choi, Hannah;
    • Knegt, Robert J.;
    • Wat, Cynthia;
    • Pavlovic, Vedran;
    • Gaggar, Anuj;
    • Xie, Qing;
    • Buti, Maria;
    • Man, Robert A.;
    • Janssen, Harry L.A.
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus.

    Published in:
    Journal of Gastroenterology & Hepatology, 2016, v. 31, n. 7, p. 1323, doi. 10.1111/jgh.13305
    By:
    • Chuang, Wan‐Long;
    • Chien, Rong‐Nan;
    • Peng, Cheng‐Yuan;
    • Chang, Ting‐Tsung;
    • Lo, Gin‐Ho;
    • Sheen, I‐Shyan;
    • Wang, Horng‐Yuan;
    • Chen, Jyh‐Jou;
    • Yang, Jenny C.;
    • Knox, Steven J.;
    • Gao, Bing;
    • Garrison, Kimberly L.;
    • Mo, Hongmei;
    • Pang, Phillip S.;
    • Hsu, Yu‐Chun;
    • Hu, Tsung‐Hui;
    • Chu, Chi‐Jen;
    • Kao, Jia‐Horng
    Publication type:
    Article
    33

    Carbon dioxide insufflation during colonoscopy can significantly decrease post-interventional abdominal discomfort in deeply sedated patients: A prospective, randomized, double-blinded, controlled trial.

    Published in:
    Journal of Gastroenterology & Hepatology, 2016, v. 31, n. 4, p. 808, doi. 10.1111/jgh.13181
    By:
    • Chen, Shuo ‐ Wei;
    • Hui, Chung ‐ Kun;
    • Chang, Jia ‐ Jang;
    • Lee, Tsung ‐ Shih;
    • Chan, Siu ‐ Cheung;
    • Chien, Cheng ‐ Hung;
    • Hu, Ching ‐ Chih;
    • Lin, Chih ‐ Lang;
    • Chen, Li ‐ Wei;
    • Liu, Ching ‐ Jung;
    • Yen, Cho ‐ Li;
    • Hsieh, Po ‐ Jen;
    • Liu, Cheng ‐ Kun;
    • Su, Chih ‐ Sheng;
    • Yu, Chia ‐ Ying;
    • Chien, Rong ‐ Nan
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Tenofovir alafenamide or tenofovir disoproxil fumarate in pregnancy to prevent HBV transmission: Maternal ALT trajectory and infant outcomes.

    Published in:
    Liver International, 2024, v. 44, n. 6, p. 1422, doi. 10.1111/liv.15873
    By:
    • Chen, Huey‐Ling;
    • Lee, Chien‐Nan;
    • Chang, Chin‐Hao;
    • Lai, Ming‐Wei;
    • Tsai, Ming‐Chieh;
    • Mu, Shu‐Chi;
    • Liu, Chun‐Jen;
    • Shih, Jin‐Chung;
    • Wen, Wan‐Hsin;
    • Hu, Rui‐Ting;
    • Huang, Chun‐Pin;
    • Hu, Kuang‐Chun;
    • Chen, Chie‐Pein;
    • Lee, Chyi‐Long;
    • Chien, Rong‐Nan;
    • Chang, Kai‐Chi;
    • Hsu, Hong‐Yuan;
    • Lee, Chien‐Chang;
    • Ni, Yen‐Hsuan;
    • Chang, Mei‐Hwei
    Publication type:
    Article
    45
    46
    47

    Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.

    Published in:
    Liver International, 2016, v. 36, n. 12, p. 1755, doi. 10.1111/liv.13253
    By:
    • Su, Tung ‐ Hung;
    • Hu, Tsung ‐ Hui;
    • Chen, Chi ‐ Yi;
    • Huang, Yi ‐ Hsiang;
    • Chuang, Wan ‐ Long;
    • Lin, Chun ‐ Che;
    • Wang, Chia ‐ Chi;
    • Su, Wei ‐ Wen;
    • Chen, Ming ‐ Yao;
    • Peng, Cheng ‐ Yuan;
    • Chien, Rong ‐ Nan;
    • Huang, Yi ‐ Wen;
    • Wang, Horng ‐ Yuan;
    • Lin, Chih ‐ Lin;
    • Yang, Sheng ‐ Shun;
    • Chen, Tsung ‐ Ming;
    • Mo, Lein ‐ Ray;
    • Hsu, Shih ‐ Jer;
    • Tseng, Kuo ‐ Chih;
    • Hsieh, Tsai ‐ Yuan
    Publication type:
    Article
    48

    A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection.

    Published in:
    Liver International, 2016, v. 36, n. 8, p. 1101, doi. 10.1111/liv.13082
    By:
    • Kao, Jia ‐ Horng;
    • Chien, Rong ‐ Nan;
    • Chang, Ting ‐ Tsung;
    • Peng, Cheng ‐ Yuan;
    • Hu, Tsung ‐ Hui;
    • Lo, Gin ‐ Ho;
    • Wang, Horng ‐ Yuan;
    • Chen, Jyh ‐ Jou;
    • Yang, Jenny C.;
    • Knox, Steven J.;
    • Han, Lingling;
    • Mo, Hongmei;
    • Mathias, Anita;
    • Brainard, Diana M.;
    • Sheen, I ‐ Shyan;
    • Hsu, Yu ‐ Chun;
    • Chu, Chi ‐ Jen;
    • Chuang, Wan ‐ Long
    Publication type:
    Article
    49
    50